These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2821409)

  • 1. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.
    Katoh I; Yasunaga T; Ikawa Y; Yoshinaka Y
    Nature; 1987 Oct 15-21; 329(6140):654-6. PubMed ID: 2821409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.
    Menéndez-Arias L; Gotte D; Oroszlan S
    Virology; 1993 Oct; 196(2):557-63. PubMed ID: 8372434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structural model for the retroviral proteases.
    Pearl LH; Taylor WR
    Nature; 1987 Sep 24-30; 329(6137):351-4. PubMed ID: 3306411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
    Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
    Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activity of the protease from bovine leukemia virus.
    Ménard A; Leonard R; Llido S; Geoffre S; Picard P; Berteau F; Precigoux G; Hospital M; Guillemain B
    FEBS Lett; 1994 Jun; 346(2-3):268-72. PubMed ID: 8013645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HTLV-I gag protease and its sequential processing of the gag gene product.
    Hatanaka M; Nam SH
    J Cell Biochem; 1989 May; 40(1):15-30. PubMed ID: 2663887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral proteases: structure, function and inhibition from a non-anticipated viral enzyme to the target of a most promising HIV therapy.
    von der Helm K
    Biol Chem; 1996 Dec; 377(12):765-74. PubMed ID: 8997487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine leukemia virus: purification and characterization of the aspartic protease.
    Menard A; Mamoun RZ; Geoffre S; Castroviejo M; Raymond S; Precigoux G; Hospital M; Guillemain B
    Virology; 1993 Apr; 193(2):680-9. PubMed ID: 8384751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins.
    Yoshinaka Y; Katoh I; Copeland TD; Smythers GW; Oroszlan S
    J Virol; 1986 Mar; 57(3):826-32. PubMed ID: 3005629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses.
    Strísovský K; Smrz D; Fehrmann F; Kräusslich HG; Konvalinka J
    Arch Biochem Biophys; 2002 Feb; 398(2):261-8. PubMed ID: 11831858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus protease characterized as a dimeric aspartic proteinase.
    Katoh I; Ikawa Y; Yoshinaka Y
    J Virol; 1989 May; 63(5):2226-32. PubMed ID: 2539514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the S-S bridge in retroviral protease function and virion maturation.
    Zábranská H; Tůma R; Kluh I; Svatos A; Ruml T; Hrabal R; Pichová I
    J Mol Biol; 2007 Feb; 365(5):1493-504. PubMed ID: 17140600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of HIV-1 proteinase by cerulenin.
    Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
    FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
    Oroszlan S; Copeland TD; Rice NR; Smythers GW; Tsai WP; Yoshinaka Y; Shimotohno K
    Princess Takamatsu Symp; 1984; 15():147-57. PubMed ID: 6100635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and inhibition of the retroviral HIV-proteinase.
    von der Helm K; Seelmeir S; Junker U
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():277-81. PubMed ID: 2205239
    [No Abstract]   [Full Text] [Related]  

  • 16. Ddi1, a eukaryotic protein with the retroviral protease fold.
    Sirkis R; Gerst JE; Fass D
    J Mol Biol; 2006 Dec; 364(3):376-87. PubMed ID: 17010377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system.
    Luukkonen BG; Tan W; Fenyö EM; Schwartz S
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2169-80. PubMed ID: 7561754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV protease cleaves poly(A)-binding protein.
    Alvarez E; Castelló A; Menéndez-Arias L; Carrasco L
    Biochem J; 2006 Jun; 396(2):219-26. PubMed ID: 16594896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
    Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
    Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and enzymatic characterization of the porcine endogenous retrovirus protease.
    Blusch JH; Seelmeir S; von der Helm K
    J Virol; 2002 Aug; 76(15):7913-7. PubMed ID: 12097607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.